This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,363.26 firm fixed-price delivery order is for the supply of Methylphenidate ER 36 mg tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/11/25, 9:42 AM